Solesence, Inc. (SLSN) stock
SLSNNasdaqPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/301% above fair value
$1.64−0.05 (-2.96%)
Close on Nov 18, 2026Market cap $115.86MP/E –Yield –
Solesence operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Solesence's operating income for the twelve months ending Jun 30, 2026 was -$1.17M, down 120.6% year over year. For fiscal 2025 it was $1.57M, down 69.4% from the year before. The highest annual figure on record is $5.13M in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.57M | -69.4% |
| FY2024 | Dec 31, 2024 | $5.13M | – |
| FY2023 | Dec 31, 2023 | -$3.55M | – |
| FY2022 | Dec 31, 2022 | -$2.26M | -188.2% |
| FY2021 | Dec 31, 2021 | $2.56M | +72.3% |
| FY2020 | Dec 31, 2020 | $1.49M | – |
| FY2019 | Dec 31, 2019 | -$2.80M | – |
| FY2018 | Dec 31, 2018 | -$2.02M | – |
| FY2017 | Dec 31, 2017 | -$772.00K | – |
| FY2016 | Dec 31, 2016 | -$1.27M | – |
| FY2015 | Dec 31, 2015 | -$1.18M | – |
| FY2014 | Dec 31, 2014 | -$1.72M | – |
| FY2013 | Dec 31, 2013 | -$2.49M | – |
| FY2012 | Dec 31, 2012 | -$2.39M | – |
| FY2011 | Dec 31, 2011 | -$3.36M | – |
| FY2010 | Dec 31, 2010 | -$4.10M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $121.00K | -95.1% |
| Q1 FY2026 | Mar 31, 2026 | -$700.00K | -373.4% |
| Q4 FY2025 | Dec 31, 2025 | $186.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$781.00K | -124.4% |
| Q2 FY2025 | Jun 30, 2025 | $2.48M | +136.5% |
| Q1 FY2025 | Mar 31, 2025 | $256.00K | -77.0% |
| Q4 FY2024 | Dec 31, 2024 | -$223.00K | – |
| Q3 FY2024 | Sep 30, 2024 | $3.20M | – |
| Q2 FY2024 | Jun 30, 2024 | $1.05M | +80.8% |
| Q1 FY2024 | Mar 31, 2024 | $1.11M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.90M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.22M | – |
| Q2 FY2023 | Jun 30, 2023 | $579.00K | +370.7% |
| Q1 FY2023 | Mar 31, 2023 | -$1.00M | -1056.2% |
| Q4 FY2022 | Dec 31, 2022 | -$1.85M | – |
| Q3 FY2022 | Sep 30, 2022 | -$634.00K | -145.3% |
| Q2 FY2022 | Jun 30, 2022 | $123.00K | -87.2% |
| Q1 FY2022 | Mar 31, 2022 | $105.00K | -78.9% |
| Q4 FY2021 | Dec 31, 2021 | -$299.00K | -192.9% |
| Q3 FY2021 | Sep 30, 2021 | $1.40M | +153.8% |
| Q2 FY2021 | Jun 30, 2021 | $960.00K | +46.8% |
| Q1 FY2021 | Mar 31, 2021 | $497.00K | – |
| Q4 FY2020 | Dec 31, 2020 | $322.00K | – |
| Q3 FY2020 | Sep 30, 2020 | $552.00K | – |
| Q2 FY2020 | Jun 30, 2020 | $654.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$43.00K | – |
| Q4 FY2019 | Dec 31, 2019 | -$914.00K | – |
| Q3 FY2019 | Sep 30, 2019 | -$815.00K | – |
| Q2 FY2019 | Jun 30, 2019 | -$597.00K | -715.5% |
| Q1 FY2019 | Mar 31, 2019 | -$470.00K | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.08M | – |
| Q3 FY2018 | Sep 30, 2018 | -$124.00K | – |
| Q2 FY2018 | Jun 30, 2018 | $97.00K | +246.4% |
| Q1 FY2018 | Mar 31, 2018 | -$913.00K | -1701.8% |
| Q4 FY2017 | Dec 31, 2017 | -$223.00K | – |
| Q3 FY2017 | Sep 30, 2017 | -$634.00K | – |
| Q2 FY2017 | Jun 30, 2017 | $28.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $57.00K | – |
| Q4 FY2016 | Dec 31, 2016 | -$706.00K | – |
| Q3 FY2016 | Sep 30, 2016 | -$422.00K | – |
See a number that looks wrong?